$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.03 | 2,892 | 26,121 | 1,672,553 | 1.7 M to 1.7 M (-0.17 %) |
Nov 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.11 | 108 | 984 | 62,562 | 62.7 K to 62.6 K (-0.17 %) |
Nov 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.11 | 2,892 | 26,340 | 1,675,445 | 1.7 M to 1.7 M (-0.17 %) |
Nov 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 88 | 748 | 62,258 | 62.3 K to 62.3 K (-0.14 %) |
Nov 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 2,348 | 19,958 | 1,667,313 | 1.7 M to 1.7 M (-0.14 %) |
Nov 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.83 | 108 | 954 | 62,346 | 62.5 K to 62.3 K (-0.17 %) |
Nov 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.83 | 2,892 | 25,548 | 1,669,661 | 1.7 M to 1.7 M (-0.17 %) |
Nov 14 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.41 | 108 | 1,016 | 63,086 | 63.2 K to 63.1 K (-0.17 %) |
Nov 14 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.41 | 2,892 | 27,202 | 1,689,461 | 1.7 M to 1.7 M (-0.17 %) |
Nov 14 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.58 | 108 | 1,035 | 63,194 | 63.3 K to 63.2 K (-0.17 %) |
Nov 14 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.58 | 2,892 | 27,705 | 1,692,353 | 1.7 M to 1.7 M (-0.17 %) |
Nov 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.02 | 279 | 2,517 | 62,670 | 62.9 K to 62.7 K (-0.44 %) |
Nov 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.02 | 7,461 | 67,313 | 1,678,337 | 1.7 M to 1.7 M (-0.44 %) |
Nov 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.34 | 137 | 1,280 | 62,949 | 63.1 K to 62.9 K (-0.22 %) |
Nov 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.34 | 3,663 | 34,220 | 1,685,798 | 1.7 M to 1.7 M (-0.22 %) |
Nov 10 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.08 | 108 | 981 | 63,518 | 63.6 K to 63.5 K (-0.17 %) |
Nov 10 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.08 | 2,892 | 26,259 | 1,701,029 | 1.7 M to 1.7 M (-0.17 %) |
Nov 10 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.24 | 108 | 998 | 63,626 | 63.7 K to 63.6 K (-0.17 %) |
Nov 10 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.24 | 2,892 | 26,734 | 1,703,921 | 1.7 M to 1.7 M (-0.17 %) |
Nov 12 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.20 | 108 | 993 | 63,302 | 63.4 K to 63.3 K (-0.17 %) |
Nov 12 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.20 | 2,892 | 26,604 | 1,695,245 | 1.7 M to 1.7 M (-0.17 %) |
Nov 12 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.98 | 108 | 970 | 63,410 | 63.5 K to 63.4 K (-0.17 %) |
Nov 12 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.98 | 2,892 | 25,967 | 1,698,137 | 1.7 M to 1.7 M (-0.17 %) |
Nov 06 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.04 | 140 | 1,406 | 63,734 | 63.9 K to 63.7 K (-0.22 %) |
Nov 06 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.04 | 3,760 | 37,758 | 1,706,813 | 1.7 M to 1.7 M (-0.22 %) |
Nov 06 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.54 | 137 | 1,445 | 63,874 | 64 K to 63.9 K (-0.21 %) |
Nov 06 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.54 | 3,663 | 38,623 | 1,710,573 | 1.7 M to 1.7 M (-0.21 %) |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.29 | 5,000 | 51,450 | 5,200 | 10.2 K to 5.2 K (-49.02 %) |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.27 | 5,000 | 51,335 | 18,033 | 23 K to 18 K (-21.71 %) |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 10.45 | 220 | 2,299 | 34,495 | 34.7 K to 34.5 K (-0.63 %) |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.24 | 108 | 1,106 | 64,011 | 64.1 K to 64 K (-0.17 %) |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.24 | 2,892 | 29,614 | 1,714,236 | 1.7 M to 1.7 M (-0.17 %) |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.85 | 108 | 1,064 | 64,119 | 64.2 K to 64.1 K (-0.17 %) |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.85 | 2,892 | 28,486 | 1,717,128 | 1.7 M to 1.7 M (-0.17 %) |
Nov 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 10.00 | 2,200 | 22,000 | 49,116 | 51.3 K to 49.1 K (-4.29 %) |
Nov 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 10.00 | 300 | 3,000 | 51,316 | 51.6 K to 51.3 K (-0.58 %) |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 94 | 799 | 64,443 | 64.5 K to 64.4 K (-0.15 %) |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 2,507 | 21,310 | 1,725,804 | 1.7 M to 1.7 M (-0.15 %) |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.89 | 106 | 942 | 64,537 | 64.6 K to 64.5 K (-0.16 %) |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.89 | 2,836 | 25,198 | 1,728,311 | 1.7 M to 1.7 M (-0.16 %) |
Nov 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.00 | 1,939 | 19,390 | 36,449 | 38.4 K to 36.4 K (-5.05 %) |
Nov 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.00 | 361 | 3,610 | 38,388 | 38.7 K to 38.4 K (-0.93 %) |
Oct 31 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.54 | 108 | 1,031 | 64,227 | 64.3 K to 64.2 K (-0.17 %) |
Oct 31 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.54 | 2,892 | 27,595 | 1,720,020 | 1.7 M to 1.7 M (-0.17 %) |
Oct 31 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.51 | 108 | 919 | 64,335 | 64.4 K to 64.3 K (-0.17 %) |
Oct 31 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.51 | 2,892 | 24,620 | 1,722,912 | 1.7 M to 1.7 M (-0.17 %) |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | M | 5.33 | 10,000 | 53,250 | 90,000 | |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | M | 0.64 | 30,000 | 19,125 | 49,931 | |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Buy | M | 5.33 | 10,000 | 53,250 | 118,736 | 108.7 K to 118.7 K (+9.20 %) |
Oct 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Buy | M | 0.64 | 30,000 | 19,125 | 108,736 | 78.7 K to 108.7 K (+38.10 %) |
Oct 27 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.70 | 108 | 1,047 | 64,643 | 64.8 K to 64.6 K (-0.17 %) |
Oct 27 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.70 | 2,892 | 28,050 | 1,731,147 | 1.7 M to 1.7 M (-0.17 %) |
Oct 27 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.76 | 108 | 1,054 | 64,751 | 64.9 K to 64.8 K (-0.17 %) |
Oct 27 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.76 | 2,892 | 28,211 | 1,734,039 | 1.7 M to 1.7 M (-0.17 %) |
Oct 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.10 | 100 | 1,010 | 38,749 | 38.8 K to 38.7 K (-0.26 %) |
Oct 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.40 | 3,100 | 32,246 | 38,849 | 41.9 K to 38.8 K (-7.39 %) |
Oct 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.48 | 108 | 1,131 | 64,859 | 65 K to 64.9 K (-0.17 %) |
Oct 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.48 | 2,892 | 30,294 | 1,736,931 | 1.7 M to 1.7 M (-0.17 %) |
Oct 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.51 | 108 | 1,135 | 64,967 | 65.1 K to 65 K (-0.17 %) |
Oct 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.51 | 2,892 | 30,404 | 1,739,823 | 1.7 M to 1.7 M (-0.17 %) |
Oct 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.51 | 2,500 | 26,263 | 41,949 | 44.4 K to 41.9 K (-5.62 %) |
Oct 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.51 | 100 | 1,151 | 44,449 | 44.5 K to 44.4 K (-0.22 %) |
Oct 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 10.73 | 1,900 | 20,393 | 44,549 | 46.4 K to 44.5 K (-4.09 %) |
Oct 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.59 | 108 | 1,143 | 65,075 | 65.2 K to 65.1 K (-0.17 %) |
Oct 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.59 | 2,892 | 30,618 | 1,742,715 | 1.7 M to 1.7 M (-0.17 %) |
Oct 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.75 | 108 | 1,161 | 65,183 | 65.3 K to 65.2 K (-0.17 %) |
Oct 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.75 | 2,892 | 31,086 | 1,745,607 | 1.7 M to 1.7 M (-0.17 %) |
Oct 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.51 | 108 | 1,135 | 65,291 | 65.4 K to 65.3 K (-0.17 %) |
Oct 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.51 | 2,892 | 30,401 | 1,748,499 | 1.8 M to 1.7 M (-0.17 %) |
Oct 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.55 | 94 | 991 | 65,399 | 65.5 K to 65.4 K (-0.14 %) |
Oct 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 11.50 | 14 | 161 | 65,493 | 65.5 K to 65.5 K (-0.02 %) |
Oct 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 10.54 | 2,507 | 26,429 | 1,751,391 | 1.8 M to 1.8 M (-0.14 %) |
Oct 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 11.50 | 385 | 4,428 | 1,753,898 | 1.8 M to 1.8 M (-0.02 %) |
Oct 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.41 | 108 | 1,340 | 65,507 | 65.6 K to 65.5 K (-0.16 %) |
Oct 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.41 | 2,892 | 35,878 | 1,754,283 | 1.8 M to 1.8 M (-0.16 %) |
Oct 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.58 | 105 | 1,321 | 65,615 | 65.7 K to 65.6 K (-0.16 %) |
Oct 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.75 | 3 | 41 | 65,720 | 65.7 K to 65.7 K (0.00 %) |
Oct 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.59 | 2,827 | 35,586 | 1,757,175 | 1.8 M to 1.8 M (-0.16 %) |
Oct 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.75 | 65 | 894 | 1,760,002 | 1.8 M to 1.8 M (0.00 %) |
Oct 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 14.76 | 1,200 | 17,708 | 10,200 | 11.4 K to 10.2 K (-10.53 %) |
Oct 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 14.75 | 1,100 | 16,228 | 23,033 | 24.1 K to 23 K (-4.56 %) |
Oct 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 14.98 | 1,900 | 28,453 | 11,400 | 13.3 K to 11.4 K (-14.29 %) |
Oct 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 14.96 | 1,800 | 26,928 | 24,133 | 25.9 K to 24.1 K (-6.94 %) |
Oct 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.06 | 1,300 | 19,582 | 13,300 | 14.6 K to 13.3 K (-8.90 %) |
Oct 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.13 | 1,300 | 19,669 | 25,933 | 27.2 K to 25.9 K (-4.77 %) |
Oct 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.08 | 600 | 9,050 | 14,600 | 15.2 K to 14.6 K (-3.95 %) |
Oct 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.08 | 800 | 12,063 | 27,233 | 28 K to 27.2 K (-2.85 %) |
Oct 02 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 15.10 | 220 | 3,322 | 34,715 | 34.9 K to 34.7 K (-0.63 %) |
Sep 30 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 16.22 | 200 | 3,245 | 51,616 | 51.8 K to 51.6 K (-0.39 %) |
Sep 30 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 15.03 | 2,300 | 34,558 | 51,816 | 54.1 K to 51.8 K (-4.25 %) |
Sep 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.02 | 103 | 1,650 | 65,723 | 65.8 K to 65.7 K (-0.16 %) |
Sep 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.02 | 2,726 | 43,662 | 1,760,067 | 1.8 M to 1.8 M (-0.15 %) |
Sep 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.77 | 182 | 2,871 | 65,826 | 66 K to 65.8 K (-0.28 %) |
Sep 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.07 | 219 | 3,737 | 66,008 | 66.2 K to 66 K (-0.33 %) |
Sep 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.77 | 4,858 | 76,630 | 1,762,793 | 1.8 M to 1.8 M (-0.27 %) |
Sep 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.06 | 5,870 | 100,160 | 1,767,651 | 1.8 M to 1.8 M (-0.33 %) |
Sep 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.02 | 108 | 1,515 | 66,227 | 66.3 K to 66.2 K (-0.16 %) |
Sep 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.00 | 11 | 176 | 66,335 | 66.3 K to 66.3 K (-0.02 %) |
Sep 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.03 | 2,892 | 40,563 | 1,773,521 | 1.8 M to 1.8 M (-0.16 %) |
Sep 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.01 | 289 | 4,628 | 1,776,413 | 1.8 M to 1.8 M (-0.02 %) |
Sep 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.13 | 108 | 1,526 | 66,346 | 66.5 K to 66.3 K (-0.16 %) |
Sep 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.13 | 2,892 | 40,861 | 1,776,702 | 1.8 M to 1.8 M (-0.16 %) |
Sep 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.13 | 108 | 1,526 | 66,454 | 66.6 K to 66.5 K (-0.16 %) |
Sep 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.13 | 2,892 | 40,852 | 1,779,594 | 1.8 M to 1.8 M (-0.16 %) |
Sep 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.07 | 158 | 2,223 | 66,562 | 66.7 K to 66.6 K (-0.24 %) |
Sep 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.07 | 4,242 | 59,689 | 1,782,486 | 1.8 M to 1.8 M (-0.24 %) |
Sep 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.09 | 108 | 1,522 | 66,720 | 66.8 K to 66.7 K (-0.16 %) |
Sep 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.09 | 2,892 | 40,757 | 1,786,728 | 1.8 M to 1.8 M (-0.16 %) |
Sep 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.71 | 108 | 1,589 | 66,828 | 66.9 K to 66.8 K (-0.16 %) |
Sep 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.71 | 2,892 | 42,544 | 1,789,620 | 1.8 M to 1.8 M (-0.16 %) |
Sep 11 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.78 | 108 | 1,488 | 66,936 | 67 K to 66.9 K (-0.16 %) |
Sep 11 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.78 | 2,892 | 39,837 | 1,792,512 | 1.8 M to 1.8 M (-0.16 %) |
Sep 11 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.79 | 205 | 2,827 | 67,044 | 67.2 K to 67 K (-0.30 %) |
Sep 11 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.79 | 5,495 | 75,771 | 1,795,404 | 1.8 M to 1.8 M (-0.31 %) |
Sep 10 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 14.83 | 3,000 | 44,496 | 54,116 | 57.1 K to 54.1 K (-5.25 %) |
Sep 09 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.91 | 108 | 1,610 | 67,249 | 67.4 K to 67.2 K (-0.16 %) |
Sep 09 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.91 | 2,892 | 43,123 | 1,800,899 | 1.8 M to 1.8 M (-0.16 %) |
Sep 09 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.75 | 108 | 1,485 | 67,357 | 67.5 K to 67.4 K (-0.16 %) |
Sep 09 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.75 | 2,892 | 39,765 | 1,803,791 | 1.8 M to 1.8 M (-0.16 %) |
Sep 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.74 | 1,200 | 16,490 | 15,200 | 16.4 K to 15.2 K (-7.32 %) |
Sep 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.74 | 1,300 | 17,866 | 28,033 | 29.3 K to 28 K (-4.43 %) |
Sep 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.85 | 1,300 | 17,999 | 16,400 | 17.7 K to 16.4 K (-7.34 %) |
Sep 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.83 | 1,200 | 16,601 | 29,333 | 30.5 K to 29.3 K (-3.93 %) |
Sep 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.76 | 108 | 1,486 | 67,465 | 67.6 K to 67.5 K (-0.16 %) |
Sep 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.76 | 2,892 | 39,785 | 1,806,683 | 1.8 M to 1.8 M (-0.16 %) |
Sep 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.72 | 108 | 1,482 | 67,573 | 67.7 K to 67.6 K (-0.16 %) |
Sep 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.72 | 2,892 | 39,690 | 1,809,575 | 1.8 M to 1.8 M (-0.16 %) |
Sep 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 13.79 | 1,200 | 16,542 | 17,700 | 18.9 K to 17.7 K (-6.35 %) |
Sep 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 13.75 | 1,300 | 17,869 | 30,533 | 31.8 K to 30.5 K (-4.08 %) |
Sep 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 13.82 | 1,300 | 17,967 | 18,900 | 20.2 K to 18.9 K (-6.44 %) |
Sep 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 13.75 | 1,300 | 17,871 | 31,833 | 33.1 K to 31.8 K (-3.92 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 13.86 | 220 | 3,049 | 34,935 | 35.2 K to 34.9 K (-0.63 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.81 | 108 | 1,492 | 67,681 | 67.8 K to 67.7 K (-0.16 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.81 | 2,892 | 39,944 | 1,812,467 | 1.8 M to 1.8 M (-0.16 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.79 | 108 | 1,490 | 67,789 | 67.9 K to 67.8 K (-0.16 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.79 | 2,892 | 39,889 | 1,815,359 | 1.8 M to 1.8 M (-0.16 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.81 | 108 | 1,492 | 67,681 | 67.8 K to 67.7 K (-0.16 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13,812.00 | 2,892 | 39,944,304 | 1,812,467 | 1.8 M to 1.8 M (-0.16 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.79 | 108 | 1,490 | 67,789 | 67.9 K to 67.8 K (-0.16 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.79 | 2,892 | 39,889 | 1,815,359 | 1.8 M to 1.8 M (-0.16 %) |
Sep 02 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 13.77 | 2,500 | 34,425 | 57,116 | 59.6 K to 57.1 K (-4.19 %) |
Aug 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.81 | 108 | 1,491 | 67,897 | 68 K to 67.9 K (-0.16 %) |
Aug 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.81 | 2,892 | 39,936 | 1,818,251 | 1.8 M to 1.8 M (-0.16 %) |
Aug 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.90 | 108 | 1,501 | 68,005 | 68.1 K to 68 K (-0.16 %) |
Aug 29 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.90 | 2,892 | 40,184 | 1,821,143 | 1.8 M to 1.8 M (-0.16 %) |
Aug 28 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 13.61 | 13,333 | 181,475 | 0 | 13.3 K to 0 (-100.00 %) |
Aug 27 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.64 | 151 | 2,059 | 68,113 | 68.3 K to 68.1 K (-0.22 %) |
Aug 27 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.64 | 4,049 | 55,224 | 1,824,035 | 1.8 M to 1.8 M (-0.22 %) |
Aug 27 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.67 | 108 | 1,476 | 68,264 | 68.4 K to 68.3 K (-0.16 %) |
Aug 27 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.67 | 2,892 | 39,528 | 1,828,084 | 1.8 M to 1.8 M (-0.16 %) |